Barclays
OPTN

Barclays’s OptiNose OPTN Stock Holding History

Barclays’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,310
Closed -$22.1K – 5467
2024
Q4 		$22.1K Sell
3,310
-1
-0% -$9 ﹤0.01% 4908
2024
Q3 		$33.3K Sell
3,311
-1,438
-30% -$21K ﹤0.01% 4823
2024
Q2 		$74.1K Sell
4,749
-1,970
-29% -$33K ﹤0.01% 4046
2024
Q1 		$147K Sell
6,719
-3,266
-33% -$72.5K ﹤0.01% 4270
2023
Q4 		$193K Buy
9,985
+5,822
+140% +$106K ﹤0.01% 4436
2023
Q3 		$76.8K Sell
4,163
-121
-3% -$2.18K ﹤0.01% 3688
2023
Q2 		$79K Buy
4,284
+446
+12% +$10.5K ﹤0.01% 3650
2023
Q1 		$111K Sell
3,838
-1,211
-24% -$32.2K ﹤0.01% 4115
2022
Q4 		$140K Buy
5,049
+1,439
+40% +$54.7K ﹤0.01% 4039
2022
Q3 		$198K Sell
3,610
-590
-14% -$32.4K ﹤0.01% 3216
2022
Q2 		$231K Sell
4,200
-281
-6% -$10.3K ﹤0.01% 3348
2022
Q1 		$166K Hold
4,481
– – ﹤0.01% 3537
2021
Q4 		$109K Sell
4,481
-338
-7% -$11.3K ﹤0.01% 3713
2021
Q3 		$217K Buy
4,819
+4,560
+1,761% +$191K ﹤0.01% 3583
2021
Q2 		$12K Sell
259
-1,691
-87% -$86.3K ﹤0.01% 4597
2021
Q1 		$107K Buy
1,950
+1,195
+158% +$72.7K ﹤0.01% 3973
2020
Q4 		$47K Sell
755
-304
-29% -$18.6K ﹤0.01% 4430
2020
Q3 		$62K Sell
1,059
-290
-21% -$21.5K ﹤0.01% 4494
2020
Q2 		$151K Buy
1,349
+530
+65% +$37.7K ﹤0.01% 4265
2020
Q1 		$55K Sell
819
-1,058
-56% -$107K ﹤0.01% 5177
2019
Q4 		$260K Buy
1,877
+1,005
+115% +$130K ﹤0.01% 4829
2019
Q3 		$92K Sell
872
-199
-19% -$19.9K ﹤0.01% 5540
2019
Q2 		$114K Buy
1,071
+683
+176% +$90K ﹤0.01% 5592
2019
Q1 		$60K Buy
+388
New +$45K ﹤0.01% 5738
2018
Q4 		– Sell
-741
Closed -$138K – 7221
2018
Q3 		$138K Buy
741
+289
+64% +$82.4K ﹤0.01% 5290
2018
Q2 		$189K Buy
452
+377
+503% +$127K ﹤0.01% 4773
2018
Q1 		$22K Buy
75
+18
+32% +$4.99K ﹤0.01% 6392
2017
Q4 		$16K Buy
+57
New +$16K ﹤0.01% 6373

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Barclays's OPTN Position: Q1 2025 in Review

Barclays sold out of OptiNose (OPTN) in Q1 2025, closing a stake of 3,310 shares — an estimated $22.1K sold.

Barclays first reported a position in OPTN in Q4 2017 and held it in 28 quarters. The position peaked at $260K in Q4 2019. 43 funds tracked by Wall St. Rank hold OPTN as of Q1 2025.

  • Barclays reported no remaining OptiNose position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 3,310 OptiNose shares in Q1 2025, an estimated $22.1K.
  • Barclays first reported a position in OptiNose in Q4 2017 and held it in 28 quarters.
  • Barclays's OptiNose position peaked at $260K in Q4 2019.
  • 43 funds tracked by Wall St. Rank held OptiNose as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.